American Journal of Cardiology
Volume 102, Issue 6 , Pages 738-742 , 15 September 2008

Stage-Related Effect of Statin Treatment on the Progression of Aortic Valve Sclerosis and Stenosis

  • Francesco Antonini-Canterin, MD

      Affiliations

    • Cardiologia Association for Research in Cardiology, Azienda Ospedaliera “S. Maria degli Angeli,” Pordenone, Italy
    • Corresponding Author InformationCorresponding author: Tel: 39-0434-399-462; fax: 39-0434-399-197
  • ,
  • Monica Hîrşu, MD

      Affiliations

    • “Prof. Dr. C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
  • ,
  • Bogdan Alexandru Popescu, MD, PhD

      Affiliations

    • “Prof. Dr. C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
  • ,
  • Elisa Leiballi, MD

      Affiliations

    • Cardiologia Association for Research in Cardiology, Azienda Ospedaliera “S. Maria degli Angeli,” Pordenone, Italy
  • ,
  • Rita Piazza, MD

      Affiliations

    • Cardiologia Association for Research in Cardiology, Azienda Ospedaliera “S. Maria degli Angeli,” Pordenone, Italy
  • ,
  • Daniela Pavan, MD

      Affiliations

    • Cardiologia Association for Research in Cardiology, Azienda Ospedaliera “S. Maria degli Angeli,” Pordenone, Italy
  • ,
  • Carmen Ginghină, MD, PhD

      Affiliations

    • “Prof. Dr. C. C. Iliescu” Institute of Cardiovascular Diseases, Bucharest, Romania
  • ,
  • Gian Luigi Nicolosi, MD

      Affiliations

    • Cardiologia Association for Research in Cardiology, Azienda Ospedaliera “S. Maria degli Angeli,” Pordenone, Italy

Received 7 March 2008 ,Revised 29 April 2008 ,Accepted 29 April 2008.

References 

  1. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–634
  2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, et al ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2006;48:e1–e148
  3. Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693–695
  4. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol. 2002;40:1723–1730
  5. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205–2209
  6. Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291–1295
  7. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Goncalves F, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554–561
  8. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–2397
  9. Otto CM. Why is aortic sclerosis associated with adverse clinical outcomes?. J Am Coll Cardiol. 2004;43:176–178
  10. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, et al. The risk of development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002;162:2345–2347
  11. Douglas PS, Khandheria B, Stainback RF, Weissman NJ. Appropriateness criteria for transthoracic and transesophageal echocardiography. J Am Coll Cardiol. 2007;50:187–204
  12. Antonini-Canterin F, Popescu BA, Huang G, Korcova-Miertusova R, Rivaben D, Faggiano P, et al. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment?. Ital Heart J. 2005;6:119–124
  13. Cheitlin M, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am SocEchocardiogr. 2003;16:1091–1110
  14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310
  15. Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, et al Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol. 2007;99:970–973
  16. Chan KL, Teo K, Tam J, Dumesnil JG. Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: The Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Am Heart J. 2007;153:925–931
  17. Liebe V, Brueckmann M, Borggrefe M, Kaden JJ. Statin therapy of calcific aortic stenosis: hype or hope?. Eur Heart J. 2006;27:773–778
  18. Griffin BP. Statins in aortic stenosis. J Am Coll Cardiol. 2007;49:562–564
  19. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007;50:1205–1213
  20. Otto CM, O'Brien KD. Why is there discordance between calcific aortic stenosis and coronary artery disease?. Heart. 2001;85:601–602
  21. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–147

 Drs. Monica Hîrşu and Bogdan A. Popescu were supported by research grants from the Association for Research in Cardiology, Pordenone, Italy.

PII: S0002-9149(08)00847-3

doi: 10.1016/j.amjcard.2008.04.056

American Journal of Cardiology
Volume 102, Issue 6 , Pages 738-742 , 15 September 2008